Effect of heterogeneous distribution of monosomy 3 on prognosis in uveal melanoma

Archives of Pathology and Laboratory Medicine

Volumn 135, Issue 8, 2011, Pages 1042-1047

  Bronkhorst, Inge H G ^a   Maat, Willem ^a   Jordanova , Ekaterina S ^a   Kroes, Wilma G M ^a   Schalij Delfos, Nicotine E ^a   Luyten, Gregorius P M ^a   Jager, Martine J ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

ARTICLE; CANCER STAGING; CHROMOSOME 3; ENUCLEATION; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENETICS; HUMAN; KARYOTYPING; MALE; MELANOMA; METASTASIS; MIDDLE AGED; MONOSOMY; MORTALITY; NETHERLANDS; PATHOLOGY; PROGNOSIS; SURVIVAL RATE; UVEA TUMOR;

CHROMOSOMES, HUMAN, PAIR 3; DNA, NEOPLASM; EYE ENUCLEATION; FEMALE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; KARYOTYPING; MALE; MELANOMA; MIDDLE AGED; MONOSOMY; NEOPLASM STAGING; NETHERLANDS; PROGNOSIS; SURVIVAL RATE; UVEAL NEOPLASMS;

EID: 80051974125     PISSN: 00039985     EISSN: 15432165     Source Type: Journal    
DOI: 10.5858/2010-0477-OAR1     Document Type: Article

References (27)

1. Kivela T, Eskelin S, Kujala E. Metastatic uveal melanoma. Int Ophthalmol Clin. 2006;46(1):133-149. (Pubitemid 44124236)
2. Mooy CM, De Jong PT. Prognostic parameters in uveal melanoma: a review. Surv Ophthalmol. 1996;41(3):215-228. (Pubitemid 26424326)
3. Maat W, Ly LV, Jordanova ES, Wolff-Rouendaal D, Schalij-Delfos NE, lager MJ. Monosomy of chromosome 3 and an inflammatory phenotype occur together in uveal melanoma. Invest Ophthal Vis Sci 2008;49(2):505-510.
4. Horsman DE, Sroka H, Rootman J, White VA. Monosomy 3 and isochromosome 8q in a uveal melanoma. Cancer Genet Cytogenet 1990;45(2):249-253. (Pubitemid 20129149)
5. Prescher G, Bornfeld N, Becher R. Nonrandom chromosomal abnormalities in primary uveal melanoma. J Natl Cancer Inst. 1990;82(22):1765-1769.
6. Sisley K, Rennie IG, Cottam DW, Potter AM, Potter CW, Rees RC. Cytogenetic findings in six posterior uveal melanomas: involvement of chromosomes 3, 6, and 8. Genes Chromosomes Cancer 1990;2(3):205-209. (Pubitemid 20369595)
7. Maat W, Jordanova ES, van Zelderen-Bhola SL, et al. The heterogeneous distribution of monosomy 3 in uveal melanomas: implications for prognostication based on fine-needle aspiration biopsies. Arch Pathol Lab Med. 2007,131 (1 ):91-96. (Pubitemid 46174141)
8. Mensink HW, Vaarwater J, Kilic E, et al. Chromosome 3 intratumor heterogeneity in uveal melanoma. Invest Ophthalmol Vis Sci. 2009;50(2):500-504.
9. Sandinha T, Farquharson M, McKay I, Roberts F. Correlation of heterogeneity for chromosome 3 copy number with cell type in choroidal melanoma of mixedcell type. Invest Ophthalmol Vis Sci. 2006;47(12):5177-5180. (Pubitemid 46723762)
10. Schoenfield L, Pettay J, Tubbs RR, Singh AD. Variation of monosomy 3 status within uveal melanoma. Arch Pathol Lab Med. 2009;133(8):1219-1222.
11. Dopierala J, Damato BE, Lake SL, Taktak AF, Coupland SE. Genetic heterogeneity in uveal melanoma assessed by multiplex ligation-dependent probe amplification. Invest Ophthalmol Vis Sci. 2010;51(10):4898-4905.
12. McLean IW, Foster WD, Zimmerman LE, Camel JW. Modifications of Calender's classification of uveal melanoma at the Armed Forces Institute of Pathology. Am ] Ophthalmol. 1983;96(4):502-509. (Pubitemid 13012002)
13. Finger PT. The 7th edition AJCC staging system for eye cancer: an international language for ophthalmic oncology. Arch Pathol Lab Med. 2009;133(8):1197-1198.
14. Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A. American Joint Committee on Cancer, Cancer Staging Manual. 7th ed. New York, NY: Springer; 2010:547-560.
15. Dauwerse JG, Jumelet EA, Wessels JW, et al. Extensive cross-homology between the long and the short arm of chromosome 16 may explain leukemic inversions and translocations, Blood 1992;79(5):1299-1304.
16. Haralambieva E, Kleiverda K, Mason DY, Schuuring E, Kluin PM. Detection of three common translocation breakpoints in non-Hodgkin's lymphomas by fluorescence in situ hybridization on routine paraffin-embedded tissue sections. J Pathol. 2002;198(2):163-170. (Pubitemid 35243874)
17. Jordanova ES, Riemersma SA, Philippo K, Giphart-Gassler M, Schuuring E, Kluin PM. Hemizygous deletions in the HLA region account for loss of heterozygosity in the majority of diffuse large B-cell lymphomas of the testis and the central nervous system. Genes Chromosomes Cancer. 2002;35(1):38-48. (Pubitemid 34847867)
18. Bronkhorst IH, Ly LV, Jordanova ES, et al. Detection of M2 macrophages in uveal melanoma and relation with survival [published online ahead of print September 1, 2010. Invest Ophthalmol Vis Sci. doi:10.1167/iovs.10-5979.
19. Meir T, Zeschnigk M, Masshofer L, Péer J, Chowers I. The spatial distribution of monosomy 3 and network vasculogenic mimicry patterns in uveal melanoma. Invest Ophthalmol Vis Sci. 2007;48(5):1918-1922. (Pubitemid 351261255)
20. Worley LA, Onken MD, Person E, et al. Transcriptomic versus chromosomal prognostic markers and clinical outcome in uveal melanoma. Clin Cancer Res. 2007;13(5):1466-1471. (Pubitemid 46450436)
21. Prescher G, Bornfeld N, Friedrichs W, Seeber S, Becher R. Cytogenetics of twelve cases of uveal melanoma and patterns of nonrandom anomalies and isochromosome formation. Cancer Genet Cytogenet 1995;80(1):40-46.
22. Hoglund M, Gisselsson D, Hansen GB et al. Dissecting karyotypic patterns in malignant melanomas: temporal clustering of losses and gains in melanoma karyotypic evolution. Int J Cancer 2004,108(1 ):57-65. (Pubitemid 37444444)
23. Kallioniemi A, Visakorpi T, Karhu R, Pinkel D, Kallioniemi OP. Gene copy number analysis by fluorescence in situ hybridization and comparative genomic hybridization. Methods 1996;9(1):113-121. (Pubitemid 26125916)
24. Patel KA, Edmondson ND, Talbot F, Parsons MA, Rennie IG, Sisley K. Prediction of prognosis in patients with uveal melanoma using fluorescence in situ hybridisation. Br J Ophthalmol. 2001;85(12):1440-1444. (Pubitemid 34032910)
25. Ly LV, Odish OF, Wolff-Rouendaal D, Missotten GS, Luyten GP, Jager MJ. Intravascular presence of tumor cells as prognostic parameter in uveal melanoma: a 35-year survey. Invest Ophthalmol Vis Sci. 2010;51(2):658-665.
26. Damato B, Duke C, Coupland SE, et al. Cytogenetics of uveal melanoma: a 7-year clinical experience. Ophthalmology 2007;114(10):1925-1931.
27. Lake SL, Coupland SE, Taktak AF, Damato BE. Whole-genome microarray detects deletions and loss of heterozygosity of chromosome 3 occurring exclusively in metastasizing uveal melanoma. Invest Ophthalmol Vis Sci. 2010;51 (101:4884-4891.